16-88599874-A-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_144604.4(ZC3H18):ā€‹c.1014A>Cā€‹(p.Glu338Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000166 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00011 ( 0 hom., cov: 33)
Exomes š‘“: 0.00017 ( 0 hom. )

Consequence

ZC3H18
NM_144604.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.371
Variant links:
Genes affected
ZC3H18 (HGNC:25091): (zinc finger CCCH-type containing 18) Enables mRNA cap binding complex binding activity and protein-macromolecule adaptor activity. Involved in RNA destabilization. Located in nuclear speck. Part of ribonucleoprotein complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.039176762).
BS2
High AC in GnomAd4 at 17 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ZC3H18NM_144604.4 linkuse as main transcriptc.1014A>C p.Glu338Asp missense_variant 6/18 ENST00000301011.10 NP_653205.3 Q86VM9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ZC3H18ENST00000301011.10 linkuse as main transcriptc.1014A>C p.Glu338Asp missense_variant 6/181 NM_144604.4 ENSP00000301011.5 Q86VM9
ZC3H18ENST00000452588.6 linkuse as main transcriptc.1086A>C p.Glu362Asp missense_variant 7/192 ENSP00000416951.2 E7ERS3
ZC3H18ENST00000567085.1 linkuse as main transcriptc.393A>C p.Glu131Asp missense_variant 4/65 ENSP00000455083.1 H3BP01
ZC3H18ENST00000568072.1 linkuse as main transcriptn.39A>C non_coding_transcript_exon_variant 1/23

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152244
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000123
AC:
31
AN:
251482
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000167
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000172
AC:
251
AN:
1461868
Hom.:
0
Cov.:
31
AF XY:
0.000173
AC XY:
126
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.000880
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000185
Gnomad4 OTH exome
AF:
0.000149
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
152244
Hom.:
0
Cov.:
33
AF XY:
0.0000941
AC XY:
7
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000262
Hom.:
0
Bravo
AF:
0.000136
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 04, 2022The c.1014A>C (p.E338D) alteration is located in exon 6 (coding exon 5) of the ZC3H18 gene. This alteration results from a A to C substitution at nucleotide position 1014, causing the glutamic acid (E) at amino acid position 338 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
7.2
DANN
Uncertain
0.98
DEOGEN2
Benign
0.077
T;.
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.82
T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.039
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;.
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-0.90
N;N
REVEL
Benign
0.18
Sift
Benign
0.24
T;T
Sift4G
Benign
0.25
T;T
Polyphen
0.0020
B;B
Vest4
0.38
MutPred
0.19
.;Loss of methylation at K367 (P = 0.1292);
MVP
0.043
MPC
0.33
ClinPred
0.041
T
GERP RS
-5.8
Varity_R
0.056
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371225285; hg19: chr16-88666282; API